Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preventive Healthcare Services01:30

Preventive Healthcare Services

1.0K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.0K
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

12.7K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
12.7K
Cancer Vaccines01:30

Cancer Vaccines

400
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
400
Cancer Survival Analysis01:21

Cancer Survival Analysis

381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-Plus): the first cross-network trial of the Cancer Prevention Clinical Trials Network (CP-CTNet).

Frontiers in immunology·2026
Same author

Developing the multidisciplinary and multispecialty workforce and the systems needed to sustain high-quality care from diagnosis through long-term survivorship.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Total Synthesis of 8-Hydroxy-dihydroergotamine, the Major Human Metabolite of Dihydroergotamine.

Molecules (Basel, Switzerland)·2026
Same author

QIM26-299: Initial Perspectives of the Health Equity Report Card (HERC) in Community Oncology Settings.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

EPR26-179: Patient Perceptions of Vaccine-Based Cancer Prevention in Lynch Syndrome.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Related Experiment Video

Updated: Jul 17, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.1K

NCCN Policy Summit: Reducing the Cancer Burden Through Prevention and Early Detection.

Lindsey Bandini1, Alyssa Schatz1, Victoria Hood1

  • 1National Comprehensive Cancer Network.

Journal of the National Comprehensive Cancer Network : JNCCN
|September 6, 2023
PubMed
Summary

Cancer prevention and early detection are crucial for improving outcomes. Successful strategies, like community engagement and genetic testing, face barriers but offer valuable lessons for reducing the global cancer burden.

More Related Videos

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:08

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

74
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

46.8K

Related Experiment Videos

Last Updated: Jul 17, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.1K
Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
08:08

Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence

Published on: June 10, 2025

74
Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

46.8K

Area of Science:

  • Oncology
  • Public Health
  • Health Policy

Background:

  • Cancer prevention, screening, and early detection significantly impact cancer incidence and patient outcomes.
  • Approximately 30% to 50% of all cancers globally are preventable.
  • Early cancer detection is strongly linked to improved treatment success rates.

Purpose of the Study:

  • To summarize discussions from the NCCN Policy Summit on reducing the cancer burden through prevention and early detection.
  • To identify challenges, successes, and future questions in current cancer prevention and early detection practices.
  • To explore the role of public health initiatives and ambitious goals like the Cancer Moonshot in cancer control.

Main Methods:

  • The content is based on a NCCN Policy Summit featuring healthcare providers, payers, policymakers, patient advocates, industry, and technology representatives.
  • Keynote presentations were delivered by leaders from the CDC and the White House Cancer Moonshot.
  • Panel discussions highlighted characteristics of effective prevention and early detection programs, including the impact of genetic testing.

Main Results:

  • High-impact prevention and early detection programs demonstrate success, with genetic testing playing a notable role.
  • Current programs often encounter challenges related to data limitations and financial, structural, and social barriers.
  • Lessons learned from successful programs, emphasizing community engagement, can be broadly applied.

Conclusions:

  • Despite existing barriers, successful cancer prevention and early detection strategies exist.
  • Applying proven attributes from successful programs, such as community engagement, is essential for broader impact.
  • Continued focus on public health strategies and ambitious initiatives is vital for reducing the overall cancer burden.